A Novel Technique to Anaesthetize the Lower Jaw

NCT ID: NCT04093713

Last Updated: 2019-09-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

65 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-09-14

Study Completion Date

2019-09-16

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study introduces and evaluates a new technique for inferior alveolar nerve blocking.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study addresses a novel technique to anaesthetize the inferior alveolar nerve depending on extraoral landmarks. Volunteers will receive bilateral blocks and evaluation of the success rate and positive aspiration rate will be performed.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Inferior Alveolar Nerve Block

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

participants

participants are subjected to a novel technique to block the inferior alveolar nerve depending on extraoral landmarks

Group Type OTHER

A novel technique to block the inferior alveolar nerve block using Mepivecaine with Levonordefrin

Intervention Type PROCEDURE

blocking the inferior alveolar nerve using extroral landmarks

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

A novel technique to block the inferior alveolar nerve block using Mepivecaine with Levonordefrin

blocking the inferior alveolar nerve using extroral landmarks

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* fitness for nerve block local anaesthesia physically and psychologically

Exclusion Criteria

* any disease or condition obstacles nerve block local anaesthesia administration such as hemophilia.
Minimum Eligible Age

5 Years

Maximum Eligible Age

55 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Mosaad Khalifah

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Mosaad Khalifah

Lecturer and researcher

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Mosaad A Khalifah, DDSc

Role: PRINCIPAL_INVESTIGATOR

Kafrelsheikh University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hosh Isa Medical Center

Ḩawsh ‘Īsá, Al-Behera, Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Mosaad A Khalifah, DDSc

Role: CONTACT

00201008603084

Ahmed A Khalil, MSc

Role: CONTACT

00201027050630

References

Explore related publications, articles, or registry entries linked to this study.

Kanaa MD, Whitworth JM, Corbett IP, Meechan JG. Articaine buccal infiltration enhances the effectiveness of lidocaine inferior alveolar nerve block. Int Endod J. 2009 Mar;42(3):238-46. doi: 10.1111/j.1365-2591.2008.01507.x.

Reference Type BACKGROUND
PMID: 19228214 (View on PubMed)

Donkor P, Wong J, Punnia-Moorthy A. An evaluation of the closed mouth mandibular block technique. Int J Oral Maxillofac Surg. 1990 Aug;19(4):216-9. doi: 10.1016/s0901-5027(05)80395-9.

Reference Type BACKGROUND
PMID: 2120362 (View on PubMed)

Montagnese TA, Reader A, Melfi R. A comparative study of the Gow-Gates technique and a standard technique for mandibular anesthesia. J Endod. 1984 Apr;10(4):158-63. doi: 10.1016/S0099-2399(84)80120-X. No abstract available.

Reference Type BACKGROUND
PMID: 6586971 (View on PubMed)

McLean C, Reader A, Beck M, Meryers WJ. An evaluation of 4% prilocaine and 3% mepivacaine compared with 2% lidocaine (1:100,000 epinephrine) for inferior alveolar nerve block. J Endod. 1993 Mar;19(3):146-50. doi: 10.1016/s0099-2399(06)80510-8.

Reference Type BACKGROUND
PMID: 8509754 (View on PubMed)

Akinosi JO. A new approach to the mandibular nerve block. Br J Oral Surg. 1977 Jul;15(1):83-7. doi: 10.1016/0007-117x(77)90011-7.

Reference Type BACKGROUND
PMID: 268212 (View on PubMed)

Boonsiriseth K, Sirintawat N, Arunakul K, Wongsirichat N. Comparative study of the novel and conventional injection approach for inferior alveolar nerve block. Int J Oral Maxillofac Surg. 2013 Jul;42(7):852-6. doi: 10.1016/j.ijom.2012.11.017. Epub 2012 Dec 21.

Reference Type BACKGROUND
PMID: 23265758 (View on PubMed)

Suazo Galdames IC, Cantin Lopez MG, Zavando Matamala DA. Inferior alveolar nerve block anesthesia via the retromolar triangle, an alternative for patients with blood dyscrasias. Med Oral Patol Oral Cir Bucal. 2008 Jan 1;13(1):E43-7.

Reference Type BACKGROUND
PMID: 18167480 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Surg192

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.